COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE

The present description relates to compounds (I), forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.In particular, the present description relates to substituted monocyclic heteroa...

Full description

Saved in:
Bibliographic Details
Main Authors SYDORENKO, Nadiya, MOON, Young-Choon, MORRILL, Christie, ZHANG, Nanjing, PATEL, Jigar S, ARNOLD, Michael A, WOLL, Matthew G, KARP, Gary Mitchell, MAZZOTTI, Anthony R, ALAM, Rauful, KENTON, Nathaniel T, MSZAR, Nicholas Walter, ZHANG, Xiaoyan, TURPOFF, Anthony, AMEDZO, Lukiana, BHATTACHARYYA, Anuradha, REN, Hongyu, NARASIMHAN, Jana, BABU, Suresh, WANG, Gang, LUONG, Tom Tuan
Format Patent
LanguageEnglish
French
German
Published 27.09.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present description relates to compounds (I), forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.
Bibliography:Application Number: EP20200729481